# Bruce G. Redman, D.O. – FDA Inspection, Jan 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/bruce-g-redman-do/656c4722-6b78-4ea4-94cc-8b361b28fcc8
Source feed: FDA_Inspections

> FDA inspection 1076345 of Bruce G. Redman, D.O., January 11, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1076345
- Company Name: Bruce G. Redman, D.O.
- Inspection Date: 2019-01-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 555423 - 2009-01-09](https://www.keypedia.com/records/fda_inspections/bruce-g-redman-do/8d0ad341-f1e6-4c32-9481-5ccfcbb5c160)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrace-deyampert/cdb4f833-488b-42b9-abab-4216435bce4c)

Company: https://www.keypedia.com/companies/bruce-g-redman-do/a82d8130-8214-457e-b221-44760923c444

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
